Nils Lonberg - 12 Sep 2024 Form 3 Insider Report for Bicara Therapeutics Inc. (BCAX)

Role
Director
Signature
/s/ Lara Meisner, Attorney-in-Fact
Issuer symbol
BCAX
Transactions as of
12 Sep 2024
Net transactions value
$0
Form type
3
Filing time
12 Sep 2024, 21:03:58 UTC
Next filing
10 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BCAX Common Stock 29,991 12 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BCAX Stock Option (Right to Buy) 12 Sep 2024 Common Stock 3,125 $4.10 Direct F1
holding BCAX Stock Option (Right to Buy) 12 Sep 2024 Common Stock 35,159 $3.79 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in sixteen equal quarterly installments following November 8, 2021, subject to the Reporting Person's continued service on each such vesting date.
F2 The shares underlying this option vest in sixteen equal quarterly installments following September 22, 2023, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney